• 364 Citations
  • 11 h-Index
20092019
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2011 PhD, Institute of Biopharmaceutical Sciences, National Cheng Kung University

Experience

  • 2018/02 ~ present Associate Professor, School of Pharmacy, National Cheng Kung University
  • 2018/02 ~ present Associate Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
  • 2014/08 ~ 2018/02 Assistant Professor, School of Pharmacy, National Cheng Kung University
  • 2013/02 ~ 2018/02 Assistant Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
  • 2011 ~ 2013 Postdoctoral Fellow, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF)

Research Interests

  • Pharmacogenomics
  • Human Microbiome
  • Personalized Medicine
  • Bioinformatics
  • Clinical pharmacy

Fingerprint Dive into the research topics where Hui-Hua Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Major Depressive Disorder Medicine & Life Sciences
Bipolar Disorder Medicine & Life Sciences
Antidepressive Agents Medicine & Life Sciences
Valproic Acid Medicine & Life Sciences
Depression Medicine & Life Sciences
C-Reactive Protein Medicine & Life Sciences
Gastrointestinal Stromal Tumors Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2018

Research Output 2009 2019

  • 364 Citations
  • 11 h-Index
  • 27 Article
  • 2 Letter
  • 1 Conference contribution
2 Citations (Scopus)
Open Access
ovaries
Polycystic Ovary Syndrome
Metformin
polymorphism
Polymorphism

Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors

Hsueh, Y. S., Chang, H. H., Shan, Y. S., Sun, H. S., Fletcher, J. A., Li, C. F. & Chen, L. T., 2019 Sep 19, In : Oncogene. 38, 38, p. 6550-6565 16 p.

Research output: Contribution to journalArticle

Open Access
Gastrointestinal Stromal Tumors
Stromal Cells
Chromatin Immunoprecipitation
Valproic Acid
Carcinogenesis
Open Access
Loneliness
Oxytocin
Social Support
Hydrocortisone
Depression
Major Depressive Disorder
Body Mass Index
Homeostasis
Fingers
Insulin Resistance
3 Citations (Scopus)
Valproic Acid
Bipolar Disorder
Therapeutics
Depression
Body Weight

Thesis

FGF21 and LEPR polymorphisms predict valproate treatment outcome in patients with bipolar II disorder

Author: 詠文, 鄭., 2018 Apr 30

Supervisor: Chang, H. (Supervisor)

Student thesis: Master's Thesis

Plasma oxytocin level and OXTR predict antidepressant treatment outcome in patients with major depressive disorder

Author: 宜靖, 彭., 2016 Aug 18

Supervisor: Chang, H. (Supervisor)

Student thesis: Master's Thesis

Predicting factors for valproate treatment outcome among bipolar II patients – focused on GNB3 and CRP level

Author: 俊頡, 李., 2015 Jul 6

Supervisor: Chang, H. (Supervisor)

Student thesis: Master's Thesis